Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TNKS2 | Q9H2K2 | 6/20 | 0.37 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.34 |
| ▸ | FER | P16591 | 1/20 | 0.34 |
| ▸ | LTK | P29376 | 1/20 | 0.34 |
| ▸ | CDK8 | P49336 | 1/20 | 0.34 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | TTK | P33981 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13294620 | 0.84 | LMNA (0.32) | TSHRLMNA | |
| SCHEMBL12333958 | 0.78 | TNKS2 (0.37) | TSHRTNKS2PBRM1ALDH1A1HPGD | |
| SCHEMBL19398067 | 0.76 | NPC1 (0.33) | TSHRLMNAALDH1A1HPGDHSD17B10 | |
| SCHEMBL29689764 | 0.75 | KMT2A (0.50) | LMNAMAOAALDH1A1HSD17B10KMT2A | |
| SCHEMBL278741 | 0.75 | KMT2A (0.50) | LMNAMAOAALDH1A1HSD17B10KMT2A | |
| SCHEMBL19004692 | 0.75 | HSPA1A (0.38) | TSHRLMNATNKS2PBRM1MAOA | |
| SCHEMBL454276 | 0.75 | HSPA1A (0.38) | TSHRLMNATNKS2PBRM1MAOA | |
| SCHEMBL15704498 | 0.75 | HSPA1A (0.38) | TSHRLMNATNKS2PBRM1MAOA | |
| SCHEMBL20884997 | 0.73 | APP (0.33) | ALDH1A1KDM4E | |
| SCHEMBL21740555 | 0.73 | CHRNB2 (0.36) | TNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024059825-A1 | SYSTEMS AND METHODS FOR QUANTIFYING USER OBSERVED VISUALIZATION OF FLUORESCENCE IMAGING AGENTS | STRYKER CORPORATION (US) | 2024-03-21 | — | — | WO | disclosed |
| US-10301203-B2 | Chloroperoxidase-catalyzed degradation of pharmaceutical pollutants in wastewater | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2019-05-28 | — | — | US | disclosed |
| US-9938176-B1 | Chloroperoxidase-catalyzed degradation of pharmaceutical pollutants in wastewater | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2018-04-10 | — | — | US | disclosed |
| EP-2471785-B1 | Novel thiophene-based dye and preparation thereof | DONGJIN SEMICHEM CO LTD (KR) | 2017-04-19 | — | — | EP | disclosed |
| US-9377466-B2 | Compounds and methods | MODPRO AB (SE) | 2016-06-28 | — | — | US | disclosed |
| US-9377466-B2 | Compounds and methods | MODPRO AB (SE) | 2016-06-28 | — | — | US | disclosed |
| US-20160083426-A1 | NON-BENZENOID AROMATIC SYSTEMS FOR IMAGING, MONITORING AND THERAPY | MEDIBEACON INC. (US) | 2016-03-24 | — | — | US | disclosed |
| US-9226980-B2 | Azulene and azaazulene systems for imaging, monitoring and therapy | MEDIBEACON INC. (US) | 2016-01-05 | — | — | US | disclosed |
| EP-2471784-B1 | Novel thiophene-based dye and preparation thereof | DONGJIN SEMICHEM CO LTD (KR) | 2015-07-08 | — | — | EP | disclosed |
| US-20130261013-A1 | Compounds and Methods | MODPRO AB (SE) | 2013-10-03 | — | — | US | disclosed |
| EP-2471784-A1 | Novel thiophene-based dye and preparation thereof | Dongjin Semichem Co., Ltd. (KR) | 2012-07-04 | — | — | EP | disclosed |
| WO-2012032068-A2 | COMPOUNDS AND METHODS | MODPRO AB (SE) | 2012-03-15 | — | — | WO | disclosed |
| WO-2011031915-A2 | NON-BENZENOID AROMATIC SYSTEMS FOR IMAGING, MONITORING AND THERAPY | MALLINCKRODT INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| US-20100061928-A1 | LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2010-03-11 | — | — | US | disclosed |
| US-7598019-B2 | Method for cleavage of labile functional groups from chemical compounds | UNIVERSITAT KONSTANZ (DE) | 2009-10-06 | — | — | US | disclosed |
| US-7598019-B2 | Method for cleavage of labile functional groups from chemical compounds | UNIVERSITAT KONSTANZ (DE) | 2009-10-06 | — | — | US | disclosed |
| US-7442447-B2 | Binaphthol based chromophores for the fabrication of blue organic light emitting diodes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-10-28 | — | — | US | disclosed |
| US-7442447-B2 | Binaphthol based chromophores for the fabrication of blue organic light emitting diodes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-10-28 | — | — | US | disclosed |
| US-7205311-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED | 2007-04-17 | — | — | US | disclosed |
| US-7205311-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100061928-A1 | LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS | HRH3, H1-3, HRH4 | TSHR 28/4885LMNA 2206/4885TNKS2 3640/4885 |
| US-20160083426-A1 | NON-BENZENOID AROMATIC SYSTEMS FOR IMAGING, MONITORING AND THERAPY | PAH, AHR, ALK | TSHR 2281/4885LMNA 3680/4885TNKS2 1361/4885 |
| US-20130261013-A1 | Compounds and Methods | NOS2, NOS1, NOS3 | TSHR 972/4885LMNA 2872/4885TNKS2 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.